{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:28:23Z","timestamp":1793039303691,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaci.2020.01.020","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T07:11:28Z","timestamp":1583305888000},"page":"725-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["Biologics for chronic rhinosinusitis with nasal polyps"],"prefix":"10.1016","volume":"145","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Weiping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elien","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Krysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.01.020_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jaci.2018.03.003","article-title":"Evolution in the surgical management of chronic rhinosinusitis: current indications and pitfalls","volume":"141","author":"Kohanski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","article-title":"Endotype-driven care pathways in patients with chronic rhinosinusitis","volume":"141","author":"Bachert","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib3","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2020.01.020_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib7","first-page":"20","article-title":"Nasal polyposis: value of blood eosinophils in surgical indications and in sinusal surgical therapy","volume":"73","author":"Taillens","year":"1952","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"10.1016\/j.jaci.2020.01.020_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM197308092890601","article-title":"Immunologic release of chemical mediators from human nasal polyps","volume":"289","author":"Kaliner","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib9","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1136\/thorax.55.suppl_2.S79","article-title":"Nasal polyposis, eosinophil dominated inflammation, and allergy","volume":"55","author":"Mygind","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.01.020_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000230229","article-title":"Immunoglobulins in nasal polyp fluid","volume":"37","author":"Donovan","year":"1970","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1081-1206(10)62426-X","article-title":"T-cell subsets (Th1 versus Th2)","volume":"85","author":"Romagnani","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00742-2018","article-title":"Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression","volume":"52","author":"Van Crombruggen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.020_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","article-title":"Differentiation of chronic sinus diseases by measurement of inflammatory mediators","volume":"61","author":"Van Zele","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2011.07.049","article-title":"Pathogenesis of chronic rhinosinusitis: inflammation","volume":"128","author":"Van Crombruggen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaci.2018.03.019","article-title":"Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps","volume":"142","author":"Kohanski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/alr.21237","article-title":"Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells","volume":"4","author":"Paris","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.01.020_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","article-title":"Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines","volume":"198","author":"Lan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2500\/ajra.2010.24.3446","article-title":"Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33","volume":"24","author":"Reh","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2016.07.010","article-title":"Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis","volume":"170","author":"Tojima","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2020.01.020_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/rccm.201402-0234OC","article-title":"Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps","volume":"190","author":"Shi","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaci.2012.04.019","article-title":"Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin","volume":"130","author":"Nagarkar","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.13489","article-title":"Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps","volume":"74","author":"Zhang","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.01.043","article-title":"Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression","volume":"131","author":"Hulse","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.02.023","article-title":"B-lymphocyte lineage cells and the respiratory system","volume":"131","author":"Kato","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00621.x","article-title":"Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue","volume":"60","author":"Gevaert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/all.12054","article-title":"Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps","volume":"68","author":"Gevaert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/cea.12287","article-title":"Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis","volume":"44","author":"Baba","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1398-9995.2010.02448.x","article-title":"Mucosal tissue polyclonal IgE is functional in response to allergen and SEB","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cea.12304","article-title":"Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps","volume":"44","author":"Cao","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4049\/jimmunol.154.2.799","article-title":"IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells","volume":"154","author":"Bochner","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1398-9995.2010.02498.x","article-title":"Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis","volume":"66","author":"Krysko","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1067\/mai.2001.118600","article-title":"IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism","volume":"108","author":"Pope","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib38","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.158.8.3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"158","author":"Simon","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib40","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"Persson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.01.020_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaci.2019.08.027","article-title":"Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis","volume":"145","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaci.2019.03.029","article-title":"Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in chronic rhinosinusitis with nasal polyps","volume":"144","author":"Wu","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib43","doi-asserted-by":"crossref","first-page":"e1341367","DOI":"10.1080\/21688370.2017.1341367","article-title":"The barrier hypothesis and Oncostatin M: restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease","volume":"5","author":"Pothoven","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jaci.2020.01.020_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.03.007","article-title":"Endotypes of chronic rhinosinusitis: pathology and therapeutic implications","author":"Bachert","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.020_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib46","first-page":"06","article-title":"Danger points, complications and medico-legal aspects in endoscopic sinus surgery","volume":"12","author":"Hosemann","year":"2013","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2020.01.020_bib47","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal interleukin-5 levels determine the response to anti-interleukin-5 treatment in nasal polyp patients","volume":"118","author":"Gevaert","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanised anti-IL-5 monoclonal antibody, as treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib49","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: a randomised trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhino09.144","article-title":"A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2020.01.020_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and non-allergic patients with nasal polyposis and co-morbid asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib52","article-title":"Efficacy and safety of omalizumab in patients with chronic rhinosinusitis with nasal polyps: results from two, multicenter, randomized, double-blind, placebo-controlled phase III trials (POLYP 1 and POLYP 2)","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.01.020_bib54","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Dupilumab efficacy and safety in severe chronic rhinosinusitis with nasal polyps in the multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trials LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.01.020_bib55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0196-0709(97)90003-X","article-title":"Interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps","volume":"18","author":"Allen","year":"1997","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaci.2020.01.020_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2500\/ajr.2006.20.2887","article-title":"Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China","volume":"20","author":"Zhang","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2020.01.020_bib58","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2019.06.023","article-title":"Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps","volume":"144","author":"Wang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib59","doi-asserted-by":"crossref","first-page":"e97581","DOI":"10.1371\/journal.pone.0097581","article-title":"Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps","volume":"9","author":"Derycke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.01.020_bib60","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1164\/ajrccm.155.4.9105087","article-title":"Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics","volume":"155","author":"Yasruel","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2008.01885.x","article-title":"Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients","volume":"64","author":"Gevaert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib63","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V73.6.1504.1504","article-title":"Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF","volume":"73","author":"Clutterbuck","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.01.020_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib65","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.01.020_bib66","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib67","doi-asserted-by":"crossref","unstructured":"Nair P, Bardin P, Humbert M, Murphy KR, Hickey L, Garin M, et\u00a0al. Efficacy of intravenous reslizumab in oral corticosteroid-dependent asthma [published online ahead of print October 15, 2019]. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2019.09.036.","DOI":"10.1016\/j.jaip.2019.09.036"},{"key":"10.1016\/j.jaci.2020.01.020_bib68","first-page":"1","article-title":"Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma","volume":"26","author":"Bourdin","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2020.01.020_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.020_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12890-019-0952-1","article-title":"Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis","volume":"19","author":"Numata","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib71","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.01.020_bib72","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti\u2013interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.01.020_bib73","first-page":"52","article-title":"Baseline patient factor impact on the clinical efficacy of benralizumab for severe asthma","volume":"18","author":"Bleecker","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.020_bib74","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaci.2018.09.039","article-title":"Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: novel biomarker of subcutaneous grass pollen immunotherapy","volume":"143","author":"Shamji","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaci.2018.10.011","article-title":"Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma","volume":"143","author":"Scheerens","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib76","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE-antibodies to staphylococcal enterotoxins in nasal polyps is associated with co-morbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib77","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","article-title":"IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy","volume":"7","author":"Humbert","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.020_bib78","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00198-2019","article-title":"Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort","volume":"54","author":"Sintobin","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.020_bib79","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01592-2019","article-title":"Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge and research needs","author":"Bachert","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.01.020_bib80","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.jaci.2019.01.018","article-title":"Non-atopic severe asthma might still be atopic: sensitization towards Staphylococcus aureus enterotoxins","volume":"143","author":"Schreiber","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms6030087","article-title":"Messing with the Sentinels\u2014the interaction of Staphylococcus aureus with dendritic cells","volume":"6","author":"Darisipudi","year":"2018","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaci.2020.01.020_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2045-7022-3-29","article-title":"Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells","volume":"3","author":"Chan","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib83","doi-asserted-by":"crossref","first-page":"e25611","DOI":"10.1371\/journal.pone.0025611","article-title":"Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component","volume":"6","author":"Mechtcheriakova","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.01.020_bib84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1939-4551-7-17","article-title":"New strategies with anti-IgE in allergic diseases","volume":"7","author":"Holgate","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2020.01.020_bib85","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/164_2016_65","article-title":"Anti-IgE and biologic approaches for the treatment of asthma","volume":"237","author":"Mitchell","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaci.2020.01.020_bib86","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in\u00a0vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"Macglashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2004.11.053","article-title":"The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation","volume":"115","author":"Holgate","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib88","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaci.2015.09.034","article-title":"Omalizumab reduces cysteinyl leukotriene and 9alpha,11beta-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease","volume":"137","author":"Hayashi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib89","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.2010.152835","article-title":"Efficacy of omalizumab in the treatment of nasal polyps","volume":"66","author":"Vennera Mdel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.01.020_bib90","doi-asserted-by":"crossref","unstructured":"Tiotiu A, Oster JP, Roux P, Nguyen Thi PL, Peiffer G, Bonniaud P, et\u00a0al. Omalizumab\u2019s effectiveness in severe allergic asthma and nasal polyps: a real-life study [published online ahead of print April 1, 2019]. J Investig Allergol Clin Immunol. https:\/\/doi.org\/10.18176\/jiaci.0391.","DOI":"10.18176\/jiaci.0391"},{"key":"10.1016\/j.jaci.2020.01.020_bib91","doi-asserted-by":"crossref","unstructured":"Manson ML, S\u00e4fholm J, James A, Johnsson AK, Bergman P, Al-Ameri M, et\u00a0al. IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways [published online ahead of print December 2, 2019]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2019.10.037.","DOI":"10.1016\/j.jaci.2019.10.037"},{"key":"10.1016\/j.jaci.2020.01.020_bib92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 cytokines: mechanisms and therapeutic strategies","volume":"15","author":"Wynn","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib93","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jaci.2020.01.020_bib94","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaci.2011.09.041","article-title":"Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity","volume":"129","author":"Barlow","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ni.2182","article-title":"Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity","volume":"13","author":"Liang","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib96","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.01.020_bib97","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/156652408785161032","article-title":"Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma","volume":"8","author":"Kuperman","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jaci.2020.01.020_bib98","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2006.06.041","article-title":"IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts","volume":"118","author":"Andrews","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12551-013-0133-z","article-title":"IL-4: an important cytokine in determining the fate of T cells","volume":"6","author":"Silva-Filho","year":"2014","journal-title":"Biophys Rev"},{"key":"10.1016\/j.jaci.2020.01.020_bib100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri3632","article-title":"The production and regulation of IgE by the immune system","volume":"14","author":"Wu","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.01.020_bib101","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1513\/AnnalsATS.201711-868MG","article-title":"Interleukin-13 stimulation reveals the cellular and functional plasticity of the airway epithelium","volume":"15","author":"Seibold","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2020.01.020_bib102","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/all.13984","article-title":"Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis","volume":"75","author":"Bachert","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib103","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.jaip.2019.03.023","article-title":"Dupilumab improves patient reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.01.020_bib104","doi-asserted-by":"crossref","unstructured":"Bachert C, Zinreich SJ, Hellings PW, Mullol J, Hamilos DL, Gevaert P, et\u00a0al. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP [published online ahead of print October 31, 2019]. Rhinology. https:\/\/doi.org\/10.4193\/Rhin18.282.","DOI":"10.4193\/Rhin18.282"},{"key":"10.1016\/j.jaci.2020.01.020_bib105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.01.020_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.01.020_bib107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/all.13823","article-title":"Medical algorithm: diagnosis and treatment of chronic rhinosinusitis","volume":"75","author":"Bachert","year":"2020","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:24:25Z","timestamp":1758792265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920301093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0091674920301093"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.020","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics for chronic rhinosinusitis with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}